ALARMED OVER a large number of malaria patients developing resistance to anti-malaria drugs, particularly chloroquine, the Regional Director (Health and Family Welfare Department) has deputed a team of technical personnel to conduct a detailed study of the symptoms of malaria patients, treatment prognosis and the prevalence rate, in malaria endemic regions of UP, including Allahabad.
The findings will be used to develop a more advance drug regime for the patients suffering from fatal plasmodium falcifarum and vivax malaria.
The six-member team has already started the study in Allahabad region. The team identified all fever patients in Koraon and Shankargarh area during the past two days and prepared their malaria slides. The patients were provided medicines and their prognosis was recorded by the team.
The team also tested the slides to identify confirmed malaria patients. It will cover all the malaria sensitive villages under primary health centres, including Meja and Jasra.
"During the 10-day visit, the team would randomly collect samples of fever patients in malaria-affected villages. The patients would be provided drug and their prognosis would be recorded," informed Dr Shantimal Singhavi, chief medical officer.
Dr Singhavi said the study would be mainly based on the patients suffering from falcifarum malaria. The effect of chloroquine on these patients would be analysed by the team, he added.
District malaria officer DN Shukla said few patients were identified in Mirzapur, who had developed resistance to anti malaria drugs like chloroquine. The team would study the malaria patients, including the resistant cases and on the basis of their findings, an advance drug regime would be probably formed by the government for malaria patients, he said.